BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7729209)

  • 21. [Do implantable insulin pumps have a value other than experimental?].
    Selam JL
    Ann Med Interne (Paris); 1992; 143(1):2-4. PubMed ID: 1605456
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal delivery of insulin via mechanical pump: surgical implications.
    Udelsman R; Boyne MS; Loman KE; Saudek CD
    Langenbecks Arch Surg; 2000 Oct; 385(6):367-72. PubMed ID: 11127519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiences with diabetes mellitus and implantable insulin pump therapy: a summary of interview data.
    Meize-Grochowski AR
    Diabetes Educ; 1989; 15(1):50-5. PubMed ID: 2910689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group.
    Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of diabetics based on blood sugar levels obtained by home-tested blood samples using filter paper].
    Petrányi G
    Orv Hetil; 1984 Nov; 125(45):2749-51. PubMed ID: 6387591
    [No Abstract]   [Full Text] [Related]  

  • 30. Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group.
    Thompson JS; Duckworth WC; Saudek CD; Giobbie-Hurder A
    Am J Surg; 1998 Dec; 176(6):622-6. PubMed ID: 9926802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs.
    Scavini M; Day PW; Eaton RP
    Artif Organs; 1992 Oct; 16(5):518-22. PubMed ID: 10078304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implanted programmable insulin pumps: one hundred fifty-three patient years of surgical experience.
    Udelsman R; Chen H; Loman K; Pitt HA; Saudek CD
    Surgery; 1997 Dec; 122(6):1005-11. PubMed ID: 9426413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total implantation of a remotely controlled insulin minipump in a human insulin-dependent diabetic.
    Selam JL; Slingeneyer A; Chaptal PA; Franetzki M; Prestele K; Mirouze J
    Artif Organs; 1982 Aug; 6(3):315-9. PubMed ID: 6758737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The world's longest user of an insulin pump?
    Orzeck EA
    Diabetes Educ; 1993; 19(4):269-70. PubMed ID: 8370328
    [No Abstract]   [Full Text] [Related]  

  • 35. The programmable implantable medication system (PIMS): design features and pre-clinical trials.
    Saudek CD; Fischell RE; Swindle MM
    Horm Metab Res; 1990 Apr; 22(4):201-6. PubMed ID: 2190901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience of long-term intraperitoneal insulin treatment using a new percutaneous access device.
    Wredling R; Adamson U; Lins PE; Backman L; Lundgren D
    Diabet Med; 1991 Jul; 8(6):597-600. PubMed ID: 1832367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic remission in a cat treated with an implantable pump to deliver insulin.
    Crinò C; Iavazzo F; Ferri F; Coppola LM; Salesov E; Lutz TA; Reusch CE; Zini E
    Can Vet J; 2020 Jan; 61(1):30-34. PubMed ID: 31892750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable insulin pumps: diagnosis and management of decreased flow rates using radionuclide investigation.
    Boulahdour H; Behar A; Haardt MJ; Selam JL
    Int J Artif Organs; 1996 Dec; 19(12):723-9. PubMed ID: 9029249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications of the pump pocket may represent a significant cause of incidents with implanted systems for intraperitoneal insulin delivery.
    Renard E; Bringer J; Jacques-Apostol D; Lauton D; Mestre C; Costalat G; Jaffiol C
    Diabetes Care; 1994 Sep; 17(9):1064-6. PubMed ID: 7988309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of implanted insulin pumps on fluorescein transcapillary escape time in type 1 diabetes mellitus.
    Ahlfors CE; Alley PA; Prendergast JJ; Parks S; Cheung AT
    Endocr Pract; 1998; 4(2):73-5. PubMed ID: 15251748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.